BioSpace News Archive

Bridge Medicines and The Rockefeller University today announced an exclusive license agreement to further develop a series of small molecule inhibitors of activated Factor XII (FXIIa) discovered in the laboratory of Jan L. Breslow, M.D.

More than 30 preeminent experts to present virtually; vast degree of structural disease change, high speed of cancer evolution, rarely considered until now [21-September-2020] BOSTON , Sept. 21, 2020 /PRNewswire/ -- Evolutionary processes have made cancer supremely difficult to treat and cure – but evolutionary thinking could hold the fundamental keys to stopping ca

Food allergy patient registry informs groundbreaking research, with patient-reported data on numbers and reasons for reactions

Therapy Brands has announced Dr. Jessica Kasirsky as their new Chief Medical Officer and Vice President of Regulatory Affairs.

Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a commercial-stage medical device company focused on developing products to treat and transform the lives of patients suffering from venous diseases, today announced that the interim results from the FLASH study have been accepted for presentation in a late-breaking clinical science session at TCT Connect. The FLASH study is evaluating the safety and effectiveness of the FlowTriever

Today, I am excited to announce an important, critical step forward in the U.S. Food and Drug Administration’s efforts to bring about farm-to-table traceability in our food supply. The FDA has prop

Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced that it is strengthening its leadership team with two appointments

City of Hope, a world-renowned independent research and treatment center for cancer, diabetes and other life-threatening diseases, today announced that it has licensed intellectual property relating to its pioneering chlorotoxin chimeric antigen receptor (CLTX-CAR) T cell therapy to Chimeric Therapeutics Limited, an Australian biotechnology company.

Veeva provides leading-edge biopharmaceutical company commercial foundation to launch innovative new medicines

This Prostate Cancer Awareness Month Prostate Oncology Specialists urges men to be mindful of what they’re consuming.